Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Allogene Therapeutics
ALLO
$604M
| $2.93M | ﹤0.01% |
1,201,655
+243,839
| +25% | +$489K |
|
2627
ArriVent BioPharma
AVBP
$1.4B
| $2.92M | ﹤0.01% |
126,525
+111,782
| +758% | +$2.52M |
|
|
DGICB
2628
Donegal Group Class B
DGICB
$800M
| $2.92M | ﹤0.01% |
164,868
-26
| -0% | -$433 |
|
|
PRMB
2629
Primo Brands
PRMB
$8.29B
| $2.9M | ﹤0.01% |
154,258
+7,320
| +5% | +$141K |
|
|
MRP
2630
Millrose Properties Inc
MRP
$4.72B
| $2.87M | ﹤0.01% |
102,647
-422,152
| -80% | -$12.7M |
|
2631
Hagerty
HGTY
$1.2B
| $2.86M | ﹤0.01% |
271,346
+89,898
| +50% | +$1.05M |
|
2632
AMCON Distributing
DIT
$63.4M
| $2.84M | ﹤0.01% |
31,583
-202
| -0.6% | -$15.2K |
|
2633
AerCap
AER
$23.9B
| $2.81M | ﹤0.01% |
20,449
+689
| +3% | +$98.5K |
|
2634
RGC Resources
RGCO
$232M
| $2.8M | ﹤0.01% |
126,931
+3,175
| +3% | +$68.7K |
|
2635
Pro-Dex
PDEX
$183M
| $2.8M | ﹤0.01% |
56,941
-5,179
| -8% | -$223K |
|
2636
Black Diamond Therapeutics
BDTX
$99.1M
| $2.77M | ﹤0.01% |
1,301,664
+444,649
| +52% | +$1.06M |
|
2637
Protara Therapeutics
TARA
$227M
| $2.77M | ﹤0.01% |
531,267
+304,110
| +134% | +$1.8M |
|
2638
Northern Technologies International Corp
NTIC
$76.3M
| $2.75M | ﹤0.01% |
333,368
-4,779
| -1% | -$42.2K |
|
2639
OmniAb
OABI
$294M
| $2.74M | ﹤0.01% |
1,745,248
-407,345
| -19% | -$735K |
|
2640
Silvercrest Asset Management
SAMG
$80.2M
| $2.74M | ﹤0.01% |
203,727
-2,357
| -1% | -$35K |
|
|
XNET
2641
Xunlei
XNET
$369M
| $2.7M | ﹤0.01% |
485,450
-1,651
| -0.3% | -$10.5K |
|
|
NOA
2642
North American Construction
NOA
$376M
| $2.7M | ﹤0.01% |
200,248
+52,605
| +36% | +$803K |
|
2643
Lakeland Industries
LAKE
$106M
| $2.7M | ﹤0.01% |
329,144
-100,858
| -23% | -$909K |
|
2644
Byrna Technologies
BYRN
$93.7M
| $2.66M | ﹤0.01% |
289,720
+25,188
| +10% | +$330K |
|
2645
Alta Equipment Group
ALTG
$208M
| $2.65M | ﹤0.01% |
492,897
-25,389
| -5% | -$161K |
|
2646
Grupo Aeroportuario Centro Norte
OMAB
$5.06B
| $2.64M | ﹤0.01% |
22,994
+93
| +0.4% | +$10.8K |
|
2647
Adaptive Biotechnologies
ADPT
$3.61B
| $2.61M | ﹤0.01% |
188,338
-1,194,586
| -86% | -$19M |
|
2648
American Vanguard Corp
AVD
$75.2M
| $2.6M | ﹤0.01% |
1,044,810
-147,337
| -12% | -$627K |
|
2649
CEMIG Preferred Shares
CIG
$6.18B
| $2.6M | ﹤0.01% |
1,087,768
+8,805
| +0.8% | +$19.4K |
|
2650
CF Bankshares
CFBK
$221M
| $2.57M | ﹤0.01% |
92,122
+30,045
| +48% | +$877K |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.